Use Of Progressive Resistance Training Research Articles

Training, Supplementation, and Pharmacological Practices of Competitive Male Bodybuilders Across Training Phases.

Hackett, DA. Training, supplementation, and pharmacological practices of competitive male bodybuilders across training phases. J Strength Cond Res 36(4): 963-970, 2022-Bodybuilding involves the pursuit of muscularity and leanness primarily through the use of progressive resistance training in combination with other practices such as manipulation of diet and use of ergogenic aids. This study aimed to compare the training practices and ergogenic aids used by competitive male bodybuilders across training phases. An online survey was completed by 235 competitive male bodybuilders with a median age of 26.0 (interquartile range 23.0-31.3) years. Results showed that most respondents performed split-routines (85.5%), 4-7 sessions per week (95.7%), trained major muscle groups twice a week (>50%), and session duration being 60-90 minutes (55.7%). Off-season resistance training sessions mostly comprised of targeting 2-3 muscle groups (56%), 2-3 exercises per muscle group (60.4%), 3-4 sets per exercise (73.2%), 7-12 repetition maximum (RM) per set (71.6%), and 61-180 seconds recovery between sets and exercises (80.5%). At the precompetition phase (6 weeks before competition), there was a decrease in the number of muscle groups trained per session (p = 0.027) and a greater number of repetitions performed per set (p < 0.001). A significant increase in the reported aerobic exercise volume was found during precompetition (<0.001). Performance enhancing drugs were used by 53.6% of respondents who did not compete in natural bodybuilding competitions. Dietary supplements were used by 95.7% of respondents with the most common being creatine monohydrate (80.4%) and whey protein (65.8%). Findings suggest that competitive bodybuilders follow resistance training practices consistent with the broad muscular hypertrophy recommendations but a notable shift in practices occur in the weeks before competition.

Lower limb progressive resistance training improves leg strength but not gait speed or balance in Parkinson's disease: a systematic review and meta-analysis.

The use of progressive resistance training (PRT) to improve gait and balance in people with Parkinson’s disease (PD) is an emerging area of interest. However, the main effects of PRT on lower limb functions such as gait, balance, and leg strength in people with PD remain unclear. Therefore, the aim of the meta-analysis is to evaluate the evidence surrounding the use of PRT to improve gait and balance in people with PD. Five electronic databases, from inception to December 2014, were searched to identify the relevant studies. Data extraction was performed by two independent reviewers and methodological quality was assessed using the PEDro scale. Standardized mean differences (SMD) and 95% confidence intervals (CIs) of fixed and random effects models were used to calculate the effect sizes between experimental and control groups and I2 statistics were used to determine levels of heterogeneity. In total, seven studies were identified consisting of 172 participants (experimental n = 84; control n = 88). The pooled results showed a moderate but significant effect of PRT on leg strength (SMD 1.42, 95% CI 0.464–2.376); however, no significant effects were observed for gait speed (SMD 0.418, 95% CI −0.219 to 1.055). No significant effects were observed for balance measures included in this review. In conclusion, our results showed no discernable effect of PRT on gait and balance measures, although this is likely due to the lack of studies available. It may be suggested that PRT be performed in conjunction with balance or task-specific functional training to elicit greater lower limb functional benefits in people with PD.

Accert: Auckland'S Cancer Cachexia Evaluating Resistance Training Study

ABSTRACT Background: Cancer Cachexia (CC) is a common problem seen in many advanced malignancies including Non- Small-Cell Lung Cancer (NSCLC). In CC there is a significant loss of adipose tissue and skeletal muscle mass. Muscle wasting is the main cause of impaired function, leading to respiratory complications and fatigue. The optimal treatment for CC is the complete removal of the tumour; unfortunately with advanced NSCLC this is unachievable. The next best options are to increase nutritional intake to counteract weight loss, address the anorexia, inflammation, and metabolic alterations i.e. loss of body fat and the skeletal muscle wasting. This requires the need to utilise a multi-targeted approach to decrease the inflammation and to stimulate the skeletal anabolic pathways with the use of progressive resistance training (PRT). PRT has shown acceptability and benefits in other cancer populations. This study aims to identify a novel multi-targeted treatment regimen that will alleviate and/or stabilise CC weight loss. Methods: This is a randomised, open-label study to investigate whether 2 sessions each week of PRT followed by essential amino acids (EAA's) high in leucine, when administered in addition to Eicosapentaenoic Acid (EPA) and a Cox-2 inhibitor is acceptable to NSCLC cachectic patients for a period of 20 weeks (primary endpoint). Secondary endpoints include Lean Body Mass, MRI thigh skeletal muscle values, QoL and Fatigue questionnaires, serum pro-inflammatory cytokine profiles, and hand and leg strength. Safety data will also be collected. Outcome measures to power a future study will be determined from the trend in difference between the two groups. 21 patients are planned to be randomised in a 1:2 ratio Arm A EPA and Cox-2 inhibitor vs. Arm B EPA, Cox-2 inhibitor, PRT followed by EAA's. All patients are offered to continue with the study medications and/or PRT sessions on compassionate use. Main inclusion criteria include: histological proven NSCLC patients who have at least 5% weight loss and fulfil the following cachectic definition (Evans Clin Nut 2008 27). A guest patient was enrolled in May 2012, followed by study participants in June 2012. Disclosure: S.P. Bird: Disclosure: Stephen P Bird is a consultant to Musashi Performance Nutrition. All other authors have declared no conflicts of interest.

Resistance training improves single leg stance performance in older adults

Age-associated losses in muscle mass, or sarcopenia, are marked by accompanying decrements in strength and muscle quality, impairing balance and increasing the risk for falls. Although progressive resistance training has been widely accepted as an appropriate modality for the treatment of sarcopenia, it has yet to offer consistent results in terms of improved balance. The purpose of the present research was to investigate the effects on static balance performance following a 6-week full-body progressive resistance training program in untrained older adults. Evaluation of magnitude-based inferences indicated the progressive resistance training intervention to be likely beneficial for improving static balance performance. These results were likely related to the strengthening of all major muscle groups by the incorporation of both free weights and resistance machines in the exercise regimen. Our findings support the use of progressive resistance training for untrained older adults to improve balance.

A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study

BackgroundCancer cachexia is a syndrome of progressive weight loss. Non-small cell lung cancer patients experience a high incidence of cachexia of 61%. Research into methods to combat cancer cachexia in various tumour sites has recently progressed to the combination of agents.The combination of the anti-cachectic agent Eicosapentaenoic acid (EPA) and the cyclo-oxygenase-2 (COX-2) inhibitor celecoxib has been tested in a small study with some benefit. The use of progressive resistance training (PRT) followed by the oral ingestion of essential amino acids (EAA), have shown to be anabolic on skeletal muscle and acceptable in older adults and other cancer groups.The aim of this feasibility study is to evaluate whether a multi-targeted approach encompassing a resistance training and nutritional supplementation element is acceptable for lung cancer patients experiencing cancer cachexia.Methods/DesignAuckland's Cancer Cachexia evaluating Resistance Training (ACCeRT) is an open label, prospective, randomised controlled feasibility study with two parallel arms. All patients will be treated with EPA and the COX-2 inhibitor celecoxib on an outpatient basis at the study site. In the experimental group patients will participate in PRT twice a week, followed by the ingestion of essential amino acids high in leucine. A total of 21 patients are planned to be enrolled. Patients will be randomised using 1:2 ratio with 7 patients enrolled into the control arm, and 14 patients into the treatment arm. The primary endpoint is the acceptability of the above multi-targeted approach, determined by an acceptability questionnaire.DiscussionTo our knowledge ACCeRT offers for the first time the opportunity to investigate the effect of stimulating the anabolic skeletal muscle pathway with the use of PRT along with EAA alongside the combination of EPA and celecoxib in this population.Trial registrationNetherlands Trial Register (NTR): ACTRN12611000870954

Treinamento resistido progressivo nas doenças musculoesqueléticas crônicas

INTRODUÇÃO: O treinamento resistido progressivo tem sido sugerido como uma modalidade terapêutica que tenta promover uma padronização da prescrição de exercícios em fisioterapia, além de otimizar os resultados da terapia. OBJETIVO: Revisar os estudos que utilizaram o treinamento resistido progressivo em doenças musculoesqueléticas crônicas e demonstrar a importância da inclusão deste tipo de treinamento na reabilitação destas doenças. FONTE DE DADOS: A pesquisa foi realizada através dos bancos de dados Pubmed, Medline e Lilacs sem restrições a datas e/ou idiomas. REVISÃO: Já se encontra bem fundamentada a importância da aplicação de exercícios terapêuticos em fisioterapia devido aos inúmeros benefícios atribuídos a esta modalidade terapêutica. Apesar de comprovadamente eficazes, os exercícios de alta intensidade ainda não são prescritos rotineiramente e esta prescrição geralmente não é feita de maneira padronizada, não nos permitindo chegar a um consenso quanto ao tipo de fortalecimento utilizado, o cálculo da carga e a sua progressão. O treinamento resistido progressivo é realizado através do aumento gradual de carga durante o período de treinamento. O número de repetições que cada indivíduo pode completar depende do cálculo da repetição máxima. CONCLUSÃO: Baseando-se nos achados desta revisão, recomenda-se o uso de exercícios resistidos progressivos como complemento dos exercícios tradicionais utilizados na reabilitação de doenças musculoesqueléticas crônicas para que seja possível padronizar os protocolos de atendimento, controlando e adequando individualmente a carga, e otimizar os resultados do treinamento. No entanto, vale ressaltar que novos estudos são necessários para que se chegue a conclusões mais fidedignas.